259 related articles for article (PubMed ID: 24993369)
1. A model for identifying cytomegalovirus in patients with inflammatory bowel disease.
McCurdy JD; Jones A; Enders FT; Killian JM; Loftus EV; Smyrk TC; Bruining DH
Clin Gastroenterol Hepatol; 2015 Jan; 13(1):131-7; quiz e7. PubMed ID: 24993369
[TBL] [Abstract][Full Text] [Related]
2. Active cytomegalovirus infection diagnosed by real-time PCR in patients with inflammatory bowel disease: a prospective, controlled observational study (.).
Thörn M; Rorsman F; Rönnblom A; Sangfelt P; Wanders A; Eriksson BM; Bondeson K
Scand J Gastroenterol; 2016 Sep; 51(9):1075-80. PubMed ID: 27142339
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus colitis in hospitalized inflammatory bowel disease patients in Taiwan: a referral center study.
Weng MT; Tung CC; Lee YS; Leong YL; Shieh MJ; Shun CT; Wang CY; Wong JM; Wei SC
BMC Gastroenterol; 2017 Feb; 17(1):28. PubMed ID: 28193173
[TBL] [Abstract][Full Text] [Related]
4. Effects of antiviral therapy for patients with inflammatory bowel disease and a positive intestinal biopsy for cytomegalovirus.
Jones A; McCurdy JD; Loftus EV; Bruining DH; Enders FT; Killian JM; Smyrk TC
Clin Gastroenterol Hepatol; 2015 May; 13(5):949-55. PubMed ID: 25283582
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study.
Biancone L; Armuzzi A; Scribano ML; D'Inca R; Castiglione F; Papi C; Angelucci E; Daperno M; Mocciaro F; Riegler G; Fries W; Meucci G; Alvisi P; Spina L; Ardizzone S; Petruzziello C; Ruffa A; Kohn A; Vecchi M; Guidi L; Di Mitri R; Renna S; Emma C; Rogai F; Rossi A; Orlando A; Pallone F;
J Crohns Colitis; 2016 Aug; 10(8):913-24. PubMed ID: 26933032
[TBL] [Abstract][Full Text] [Related]
6. Human herpesvirus 6 and cytomegalovirus in ileocolonic mucosa in inflammatory bowel disease.
Sipponen T; Turunen U; Lautenschlager I; Nieminen U; Arola J; Halme L
Scand J Gastroenterol; 2011 Nov; 46(11):1324-33. PubMed ID: 21879802
[TBL] [Abstract][Full Text] [Related]
7. Outcome of cytomegalovirus infections in patients with inflammatory bowel disease.
Papadakis KA; Tung JK; Binder SW; Kam LY; Abreu MT; Targan SR; Vasiliauskas EA
Am J Gastroenterol; 2001 Jul; 96(7):2137-42. PubMed ID: 11467645
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus, inflammatory bowel disease, and anti-TNFα.
Campos ST; Portela FA; Tomé L
Int J Colorectal Dis; 2017 May; 32(5):645-650. PubMed ID: 28084548
[TBL] [Abstract][Full Text] [Related]
9. The prevalence and risk factors of cytomegalovirus infection in inflammatory bowel disease in Wuhan, Central China.
Yi F; Zhao J; Luckheeram RV; Lei Y; Wang C; Huang S; Song L; Wang W; Xia B
Virol J; 2013 Feb; 10():43. PubMed ID: 23374225
[TBL] [Abstract][Full Text] [Related]
10. Low frequency of cytomegalovirus infection during exacerbations of inflammatory bowel diseases.
Lévêque N; Brixi-Benmansour H; Reig T; Renois F; Talmud D; Brodard V; Coste JF; De Champs C; Andréoletti L; Diebold MD
J Med Virol; 2010 Oct; 82(10):1694-700. PubMed ID: 20827767
[TBL] [Abstract][Full Text] [Related]
11. Frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel disease.
Dimitroulia E; Spanakis N; Konstantinidou AE; Legakis NJ; Tsakris A
Inflamm Bowel Dis; 2006 Sep; 12(9):879-84. PubMed ID: 16954807
[TBL] [Abstract][Full Text] [Related]
12. Steroid-refractory inflammatory bowel disease is a risk factor for CMV infection.
Ormeci AC; Akyuz F; Baran B; Soyer OM; Gokturk S; Onel M; Onel D; Agacfidan A; Demirci M; Yegen G; Gulluoglu M; Karaca C; Demir K; Besisik F; Kaymakoglu S
Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):858-65. PubMed ID: 27010142
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of inflammatory bowel diseases with cytomegalovirus colitis: effect of antiviral treatment.
Maconi G; Lombardini M; Furfaro F; Bezzio C; Zerbi P; Ardizzone S
Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1146-51. PubMed ID: 25089547
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus disease in inflammatory bowel disease: epidemiology and disease characteristics in a large single-centre experience.
Bontà J; Zeitz J; Frei P; Biedermann L; Sulz MC; Vavricka SR; Scharl S; Fried M; Rogler G; Scharl M
Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1329-34. PubMed ID: 27482785
[TBL] [Abstract][Full Text] [Related]
15. Intestinal cytomegalovirus infection in patients hospitalized for exacerbation of inflammatory bowel disease: a 10-year tertiary referral center experience.
Gauss A; Rosenstiel S; Schnitzler P; Hinz U; Rehlen T; Kadmon M; Ehehalt R; Stremmel W; Zawierucha A
Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):712-20. PubMed ID: 25919654
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy.
D'Ovidio V; Vernia P; Gentile G; Capobianchi A; Marcheggiano A; Viscido A; Martino P; Caprilli R
J Clin Virol; 2008 Oct; 43(2):180-3. PubMed ID: 18614396
[TBL] [Abstract][Full Text] [Related]
17. Relationship Between Cytomegalovirus Infection and Steroid Resistance in Inflammatory Bowel Disease: A Meta-Analysis.
Wu XW; Wu L; Ji HZ; Wang FY
Dig Dis Sci; 2015 Nov; 60(11):3203-8. PubMed ID: 26031424
[TBL] [Abstract][Full Text] [Related]
18. Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel disease.
Maher MM; Nassar MI
Dig Dis Sci; 2009 Nov; 54(11):2456-62. PubMed ID: 19093204
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus-related colitis in patients with inflammatory bowel disease.
Kwon J; Fluxá D; Farraye FA; Kröner PT
Int J Colorectal Dis; 2022 Mar; 37(3):685-691. PubMed ID: 35132443
[TBL] [Abstract][Full Text] [Related]
20. Association between pharmacokinetics of adalimumab and mucosal healing in patients with inflammatory bowel diseases.
Roblin X; Marotte H; Rinaudo M; Del Tedesco E; Moreau A; Phelip JM; Genin C; Peyrin-Biroulet L; Paul S
Clin Gastroenterol Hepatol; 2014 Jan; 12(1):80-84.e2. PubMed ID: 23891927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
